المؤلفون: José López-Sendón, Robert N. Doughty, Gillian A. Whalley, H. Walsh, Greg D. Gamble, Norman Sharpe

المصدر: Circulation. 109:201-206

مصطلحات موضوعية: Male, medicine.medical_specialty, Heart disease, Adrenergic beta-Antagonists, Carbazoles, Myocardial Infarction, Infarction, Blood Pressure, Placebo, law.invention, Propanolamines, Randomized controlled trial, Heart Rate, law, Physiology (medical), Internal medicine, medicine, Humans, Myocardial infarction, Ventricular remodeling, Carvedilol, Ultrasonography, Ejection fraction, Ventricular Remodeling, business.industry, Middle Aged, medicine.disease, Kinetics, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6629f60765b2751f0284433baacbae5
https://doi.org/10.1161/01.cir.0000108928.25690.94

المؤلفون: Burkert, Pieske, Mahesh J, Patel, Cynthia M, Westerhout, Kevin J, Anstrom, Javed, Butler, Justin, Ezekowitz, Adrian F, Hernandez, Joerg, Koglin, Carolyn S P, Lam, Piotr, Ponikowski, Lothar, Roessig, Adriaan A, Voors, Christopher M, O'Connor, Paul W, Armstrong, Jian, Zhang

المساهمون: leboeuf, Christophe, Charité Campus Virchow-Klinikum (CVK), German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Merck & Co. Inc. [Kenilworth, NJ, USA], University of Alberta, Duke University Medical Center, University of Mississippi Medical Center (UMMC), King‘s College London, University of Wrocław [Poland] (UWr), Bayer Pharma AG [Berlin], University Medical Center Groningen [Groningen] (UMCG), Duke University [Durham], VICTORIA Study Group: Imran Zainal Abidin, Dan Atar, M Cecilia Bahit, Juan Luis Arango Benecke, Edimar A Bocchi, Diana Bonderman, Myeong-Chan Cho, Chern-En Chiang, Alain Cohen-Solal, Martin Cowie, Frank Edelmann, Michele Emdin, Jorge Escobedo, Justin A Ezekowitz, Michael M Givertz, David M Kaye, Fernando Lanas, Johan Lassus, Basil S Lewis, Yury Lopatin, José López-Sendón, Lars H Lund, Kenneth McDonald, Vojtěch Melenovský, Arend Mosterd, Ebrahim Noori, M Ali Oto, Armando Lionel Godoy Palomino, Ileana L Piña, Piotr Ponikowski, Anne-Catherine Pouleur, Jens Refsgaard, Eugene Reyes, Clara Saldarriaga, Michele Senni, David Sim, David Siu, Karen Sliwa-Hähnle, Nancy K Sweitzer, Richard W Troughton, Hiroyuki Tsutsui, Dimitrios N Tziakas, Jose B Vazquez-Tanus, Jian Zhang., Cardiovascular Centre (CVC)

المصدر: Pieske, B, Patel, M J, Westerhout, C M, Anstrom, K J, Butler, J, Ezekowitz, J, Hernandez, A F, Koglin, J, Lam, C S P, Ponikowski, P, Roessig, L, Voors, A A, O'Connor, C M, Armstrong, P W & VICTORIA Study Group 2019, ' Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial ', European Journal of Heart Failure, vol. 21, no. 12, pp. 1596-1604 . https://doi.org/10.1002/ejhf.1664
European Journal of Heart Failure
European Journal of Heart Failure, 2019, 21 (12), pp.1596-1604. ⟨10.1002/ejhf.1664⟩
European Journal of Heart Failure, 21(12), 1596-1604. Wiley

مصطلحات موضوعية: Male, 030204 cardiovascular system & hematology, Coronary artery disease, 0302 clinical medicine, Interquartile range, Natriuretic Peptide, Brain, Heart Failure/blood, Myocardial infarction, Prospective Studies, education.field_of_study, Framingham Risk Score, Ejection fraction, Atrial fibrillation, Heart failure with reduced ejection fraction, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Clinical trial, Treatment Outcome, STIMULATOR, ENALAPRIL, Cardiology, Female, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Population, Heterocyclic Compounds, 2-Ring, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, medicine, SOLUBLE GUANYLATE-CYCLASE, Humans, Soluble guanylate cyclase, Cyclic guanosine monophosphate, Protein Precursors, education, Heterocyclic Compounds, 2-Ring/therapeutic use, Aged, Heart Failure, business.industry, Pyrimidines/therapeutic use, Stroke Volume, medicine.disease, Peptide Fragments, Pyrimidines, Stroke Volume/physiology, Heart failure, Natriuretic Peptide, Brain/blood, business, Peptide Fragments/blood, Biomarkers, Biomarkers/blood, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c0559faf46b4ff186b6cd3dfba3f3e
https://pure.au.dk/portal/da/publications/baseline-features-of-the-victoria-vericiguat-global-study-in-subjects-with-heart-failure-with-reduced-ejection-fraction-trial(abef0460-5e68-4f8f-9aab-7efe513d1837).html